Search

Carbon monoxide

The European Union has banned the use of carbon monoxide as a color stabilizer in meat and fish. … A December 2001 report from the European Commission's Scientific Committee on Food concluded that the gas did not pose a risk provided that food was maintained adequately cold during storage and transport

Voriconazole

[A236050] Voriconazole was approved by the FDA under the trade name Vfend on May 24, 2002.[L34660]

Lamotrigine

It is used in the treatment of both epilepsy and as a mood stabilizer in bipolar disorder. … [A191350] Lamotrigine has relatively few side-effects and does not require laboratory monitoring.

Bisoprolol

A180472] Bisoprolol is generally well tolerated, likely due to its β1-adrenergic receptor selectivity and is a useful alternative to non-selective β-blocker drugs in the treatment of hypertension such as

Gliclazide

It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of … Gliclazide has been shown to decrease fasting plasma glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels (reflective of the last 8-10 weeks of glucose control).

Nirmatrelvir

[L46921] Paxlovid was approved for use in Canada in January 2022 for the treatment of adult patients with mild-moderate COVID-19 [L39544] and later granted conditional marketing authorization by the European … [L39544] It was fully approved by the FDA on May 25, 2023.

Riociguat

Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for

Benzoyl peroxide

[A18903,A233859] This treatment decreases keratin and sebum around follicles, as well as increasing turnover of epithelial cells. … [L33249,L33264,L33269,L33299,L33314] It has been formulated as products with either a single active ingredient,[L33249,L33299] or with [erythromycin],[L33264] [clindamycin],[L33269] or [adapalene].

Intermedine

Maralixibat

granted marketing authorization in Europe on 13 December 2022. … [A239249] Surgical interventions such as partial external bile diversion and ileal exclusion have also been used as treatments.